Preliminary timetable
Wednesday 3 June: 08:00 to 17:30, Welcome reception and social activities to follow
Thursday 4 June: 08:00 to 17:30, Conference dinner to follow
Friday 5 June: 08:00 to 13:00
Keynote speakers
We are proud to feature five leading voices in epidemiology and pharmacoepidemiology.
Yu-Han Chu, MD, ScD, is an Assistant Professor in the Department of Epidemiology at the Brown University School of Public Health. Her research focuses on developing and applying novel causal inference methods—such as target trial emulation and methods for transportability—to improve decision-making in pregnancy and cardiovascular health. She is a recipient of the NIH Maximizing Investigators’ Research Award. Dr. Chiu received her MD from National Taiwan University and her ScD in Epidemiology and Nutrition from the Harvard T.H. Chan School of Public Health.
Anton Pottegård, PhD, is a professor of pharmacoepidemiology at the University of Southern Denmark, leading the pharmacoepi research group currently counting around 50 people. He is doing applied pharmacoepi within many different disease areas, with a particular focus on building infrastructure and best practice, in particular on transparency and reproducibility, around use of secondary health data.
Unnur Anna Valdimarsdóttir, PhD, is a professor of epidemiology and dean of the School of Health Sciences at the University of Iceland. Her research is focused on the complex links between psychological trauma, psychiatric disorders and somatic diseases and her team leverage various Nordic register-cohort-biobank resources and family designs to make advances in this area with support from e.g. the European Research Council (StressGene) and NordForsk (COVIDMENT).
Walter Ricciardi, MD, Hon PhD, is a full Professor of Hygiene and Director of the School of Public Health of the Università Cattolica del Sacro Cuore (Rome). He is the President of the Mission Board for Cancer of the European Commission and of the European Mission Board of Vaccination.
Camilla Stoltenberg, MD, PhD, is a physician and epidemiologist who is currently the Chief Executive Officer of NORCE and served as Director-General of the Norwegian Institute of Public Health from 2012 to 2023 during the Covid-19 pandemic. Her research spans population health, social determinants of health, and the use of large-scale registries, biobanks, and cohort data to understand health across the life course. She holds a PhD in epidemiology from the University of Oslo and has also studied sociology and medical anthropology in Oslo and at the University of California, Berkeley and San Francisco. She is an adjunct professor at the University of Bergen and has led research projects funded by the EU, the Research Council of Norway, and the NIH.